These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33545341)

  • 1. Systematic transcriptome-based comparison of cellular adaptive stress response activation networks in hepatic stem cell-derived progeny and primary human hepatocytes.
    Ter Braak B; Niemeijer M; Boon R; Parmentier C; Baze A; Richert L; Huppelschoten S; Wink S; Verfaillie C; van de Water B
    Toxicol In Vitro; 2021 Jun; 73():105107. PubMed ID: 33545341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
    Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
    J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing in vitro human liver models to in vivo human liver using RNA-Seq.
    Gupta R; Schrooders Y; Hauser D; van Herwijnen M; Albrecht W; Ter Braak B; Brecklinghaus T; Castell JV; Elenschneider L; Escher S; Guye P; Hengstler JG; Ghallab A; Hansen T; Leist M; Maclennan R; Moritz W; Tolosa L; Tricot T; Verfaillie C; Walker P; van de Water B; Kleinjans J; Caiment F
    Arch Toxicol; 2021 Feb; 95(2):573-589. PubMed ID: 33106934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use.
    Ardisasmita AI; Schene IF; Joore IP; Kok G; Hendriks D; Artegiani B; Mokry M; Nieuwenhuis EES; Fuchs SA
    Commun Biol; 2022 Oct; 5(1):1094. PubMed ID: 36241695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
    Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
    PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.
    Kvist AJ; Kanebratt KP; Walentinsson A; Palmgren H; O'Hara M; Björkbom A; Andersson LC; Ahlqvist M; Andersson TB
    Biochem Pharmacol; 2018 Sep; 155():124-140. PubMed ID: 29953844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.
    Gao X; Li R; Cahan P; Zhao Y; Yourick JJ; Sprando RL
    Stem Cell Res Ther; 2020 Sep; 11(1):393. PubMed ID: 32917265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice.
    Yuan L; Zhang Y; Liu X; Chen Y; Zhang L; Cao J; Li X; Wang M; Wu K; Zhang J; Liu G; Tang Q; Yuan Q; Cheng T; Xia N
    Theranostics; 2019; 9(7):2115-2128. PubMed ID: 31037160
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells.
    Nell P; Kattler K; Feuerborn D; Hellwig B; Rieck A; Salhab A; Lepikhov K; Gasparoni G; Thomitzek A; Belgasmi K; Blüthgen N; Morkel M; Küppers-Munther B; Godoy P; Hay DC; Cadenas C; Marchan R; Vartak N; Edlund K; Rahnenführer J; Walter J; Hengstler JG
    J Hepatol; 2022 Nov; 77(5):1386-1398. PubMed ID: 35863491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes.
    Xu Z; He X; Shi X; Xia Y; Liu X; Wu H; Li P; Zhang H; Yin W; Du X; Li L; Li Y
    Stem Cell Res Ther; 2018 Aug; 9(1):211. PubMed ID: 30092828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent toxicogenomic changes of silver nanoparticles in hepatocyte-like cells derived from human induced pluripotent stem cells.
    Gao X; Li R; Sprando RL; Yourick JJ
    Cell Biol Toxicol; 2021 Apr; 37(2):245-259. PubMed ID: 32447489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
    Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Human Pluripotent Stem Cell-Derived Hepatic Cell Phenotype by Three-Dimensional Hydrogel Models.
    Toivonen S; Malinen MM; Küblbeck J; Petsalo A; Urtti A; Honkakoski P; Otonkoski T
    Tissue Eng Part A; 2016 Jul; 22(13-14):971-84. PubMed ID: 27329070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of liver zonation-like transcriptomic patterns in HLCs derived from hiPSCs in a microfluidic biochip environment.
    Danoy M; Poulain S; Lereau-Bernier M; Kato S; Scheidecker B; Kido T; Miyajima A; Sakai Y; Plessy C; Leclerc E
    Biotechnol Prog; 2020 Sep; 36(5):e3013. PubMed ID: 32364651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity.
    Choudhury Y; Toh YC; Xing J; Qu Y; Poh J; Li H; Tan HS; Kanesvaran R; Yu H; Tan MH
    Sci Rep; 2017 Jan; 7():41238. PubMed ID: 28120901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
    Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α
    Segeritz CP; Rashid ST; de Brito MC; Serra MP; Ordonez A; Morell CM; Kaserman JE; Madrigal P; Hannan NRF; Gatto L; Tan L; Wilson AA; Lilley K; Marciniak SJ; Gooptu B; Lomas DA; Vallier L
    J Hepatol; 2018 Oct; 69(4):851-860. PubMed ID: 29879455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.
    Deguchi S; Yamashita T; Igai K; Harada K; Toba Y; Hirata K; Takayama K; Mizuguchi H
    Drug Metab Dispos; 2019 Jun; 47(6):632-638. PubMed ID: 30962288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Human Induced Pluripotent Stem Cell-Derived Hepatocytes with Mature Features and Potential for Modeling Metabolic Diseases.
    Holmgren G; Ulfenborg B; Asplund A; Toet K; Andersson CX; Hammarstedt A; Hanemaaijer R; Küppers-Munther B; Synnergren J
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.